235 related articles for article (PubMed ID: 1452775)
1. p53 expression in lymphatic malignancies.
Soini Y; Pääkkö P; Alavaikko M; Vähäkangas K
J Clin Pathol; 1992 Nov; 45(11):1011-4. PubMed ID: 1452775
[TBL] [Abstract][Full Text] [Related]
2. Tenascin in reactive lymph nodes and in malignant lymphomas.
Soini Y; Alavaikko M; Lehto VP; Virtanen I
Pathol Res Pract; 1992 Dec; 188(8):1078-82. PubMed ID: 1284450
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical analysis of p53 expression in malignant lymphomas.
Said JW; Barrera R; Shintaku IP; Nakamura H; Koeffler HP
Am J Pathol; 1992 Dec; 141(6):1343-8. PubMed ID: 1466398
[TBL] [Abstract][Full Text] [Related]
4. Dendritic reticulum cell immunoreactivity for low-affinity nerve growth factor receptor in malignant lymphomas.
Dorfman DM; Shahsafaei A
Mod Pathol; 1996 Oct; 9(10):959-65. PubMed ID: 8902831
[TBL] [Abstract][Full Text] [Related]
5. P53 protein expression in lymphomas and reactive lymphoid tissue.
Villuendas R; Piris MA; Orradre JL; Mollejo M; Algara P; Sanchez L; Martinez JC; Martinez P
J Pathol; 1992 Mar; 166(3):235-41. PubMed ID: 1381424
[TBL] [Abstract][Full Text] [Related]
6. Demonstration of immunoglobulin production by tumor cells in non-Hodgkin's and Hodgkin's malignant lymphomas and its significance for their classification.
Stein H; Papadimitriou CS; Bouman H; Lennert K; Fuchs J
Recent Results Cancer Res; 1978; 64():158-75. PubMed ID: 366694
[TBL] [Abstract][Full Text] [Related]
7. High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma.
van den Berg A; Visser L; Poppema S
Am J Pathol; 1999 Jun; 154(6):1685-91. PubMed ID: 10362793
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic protein expression in non-Hodgkin's lymphomas and Hodgkin's disease.
Kanavaros P; Vlychou M; Stefanaki K; Rontogianni D; Gaulard P; Pantelidaki E; Zois M; Darivianaki K; Georgoulias V; Boulland ML; Gorgoulis V; Kittas C
Anticancer Res; 1999; 19(2A):1209-16. PubMed ID: 10368677
[TBL] [Abstract][Full Text] [Related]
9. p53, c-myc p62 and proliferating cell nuclear antigen (PCNA) expression in non-Hodgkin's lymphomas.
Korkolopoulou P; Oates J; Kittas C; Crocker J
J Clin Pathol; 1994 Jan; 47(1):9-14. PubMed ID: 7907610
[TBL] [Abstract][Full Text] [Related]
10. Abundance of heat shock proteins (hsp89, hsp60, and hsp27) in malignant cells of Hodgkin's disease.
Hsu PL; Hsu SM
Cancer Res; 1998 Dec; 58(23):5507-13. PubMed ID: 9850087
[TBL] [Abstract][Full Text] [Related]
11. Histopathologic features of high-grade non-Hodgkin's lymphomas in acquired immunodeficiency syndrome. The French Study Group of Pathology for Human Immunodeficiency Virus-Associated Tumors.
Raphael M; Gentilhomme O; Tulliez M; Byron PA; Diebold J
Arch Pathol Lab Med; 1991 Jan; 115(1):15-20. PubMed ID: 1987908
[TBL] [Abstract][Full Text] [Related]
12. Malignant lymphomas involving the central nervous system--a morphological and immunohistochemical study of 32 cases.
Simon J; Jones EL; Trumper MM; Salmon MV
Histopathology; 1987 Apr; 11(4):335-49. PubMed ID: 3596473
[TBL] [Abstract][Full Text] [Related]
13. High-grade malignant non-Hodgkin's lymphomas differ from low-grade lymphomas in the extent of apoptosis and their expression of bcl-2, mcl-1, bax and p53.
Soini Y; Raunio H; Pääkkö P
Tumour Biol; 1998; 19(3):176-85. PubMed ID: 9591044
[TBL] [Abstract][Full Text] [Related]
14. CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas.
Miettinen M
Arch Pathol Lab Med; 1992 Nov; 116(11):1197-201. PubMed ID: 1332642
[TBL] [Abstract][Full Text] [Related]
15. Expression of vimentin and epithelial membrane antigen in human malignant lymphomas.
Sarker AB; Akagi T; Yoshino T; Hoshida Y; Takahashi K; Horie Y
Acta Pathol Jpn; 1990 Aug; 40(8):581-7. PubMed ID: 2239313
[TBL] [Abstract][Full Text] [Related]
16. Expression of bcl-2 oncogene product in primary non-Hodgkin's malignant lymphoma of the oral cavity.
Takahashi H; Kawazoe K; Fujita S; Okabe H; Hideshima K; Tsuda N; Tezuka F
Pathol Res Pract; 1996 Jan; 192(1):44-53. PubMed ID: 8685041
[TBL] [Abstract][Full Text] [Related]
17. Fascin, a sensitive new marker for Reed-Sternberg cells of hodgkin's disease. Evidence for a dendritic or B cell derivation?
Pinkus GS; Pinkus JL; Langhoff E; Matsumura F; Yamashiro S; Mosialos G; Said JW
Am J Pathol; 1997 Feb; 150(2):543-62. PubMed ID: 9033270
[TBL] [Abstract][Full Text] [Related]
18. Reed-Sternberg-like cells in low-grade lymphomas are transformed neoplastic cells of B-cell lineage.
Shin SS; Ben-Ezra J; Burke JS; Sheibani K; Rappaport H
Am J Clin Pathol; 1993 Jun; 99(6):658-62. PubMed ID: 8322699
[TBL] [Abstract][Full Text] [Related]
19. The expression of p53 protein in non-Hodgkin's lymphomas is not always dependent on p53 gene mutations.
Villuendas R; Piris MA; Algara P; Sánchez-Beato M; Sánchez-Verde L; Martinez JC; Orradre JL; García P; Lopez C; Martinez P
Blood; 1993 Nov; 82(10):3151-6. PubMed ID: 8219204
[TBL] [Abstract][Full Text] [Related]
20. Expression of p53, p21/waf1, bcl-2, bax, Rb and Ki67 proteins in Hodgkin's lymphomas.
Kanavaros P; Stefanaki K; Vlachonikolis J; Eliopoulos G; Kakolyris S; Rontogianni D; Gorgoulis V; Georgoulias V
Histol Histopathol; 2000 Apr; 15(2):445-53. PubMed ID: 10809363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
